News

Yahoo Finance5mon
Beta Lactam and Beta Lactamase Inhibitors Market to grow by USD 8.4 Billion from 2025-2029, driven by novel drug development, with AI driving market transformation - Technavio
These advancements contribute to the discovery of improved beta lactam antibiotics and beta lactamase inhibitors, addressing antimicrobial resistance and infectious diseases.
PharmiWeb1y
Beta-lactam and Beta-lactamase Inhibitors Market: Emerging Trends and Therapeutic Innovations for Antibiotic Resistance
The Beta-lactam and Beta-lactamase Inhibitors Market encompasses a wide range of antibiotics and enzyme inhibitors used in the treatment of various bacterial infections. Beta-lactams are a class of ...
Business Insider5y
The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from ...
NEW YORK, Oct. 1, 2019 /PRNewswire/ -- Beta-lactam and Beta-lactamase Inhibitors Market by Drug Class (Penicillin, Cephalosporin, Carbapenem, Monobactam, and Combination), Disease (Urinary Tract ...
Yahoo Finance4mon
Beta Lactam and Beta Lactamase Inhibitors Market to grow by USD 8.4 Billion (2025-2029), driven by novel drug development, AI-powered market evolution - Technavio
Amalgamation traits of Beta Lactam and Beta Lactamase Inhibitors offer effective solutions to combat antibiotic resistance. Creative Diagnostics is a leading supplier of Beta Lactamase Inhibitors ...